Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis
Pediatric Dermatology · 2024-05 · 41 (3) · 438-444
DOI: 10.1111/pde.15575 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Dermatology, online erschienen am 27.02.2024. Verfasst von Amy S Paller und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Northwestern University Feinberg School of Medicine and the Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Molluscum Contagiosum, Gels. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Novan Inc.
Abstract (Originalsprache)
Objective
Controlling molluscum contagiosum (MC) infections is critical in atopic dermatitis (AD) management. This post hoc analysis assessed the efficacy and safety of berdazimer gel, 10.3% (topical, antiviral, nitric oxide–releasing medication) versus vehicle in MC patients with or without AD.
Methods
Three Phase 3, multicenter, randomized, double‐blind, vehicle‐controlled, parallel‐group trials (B‐SIMPLE[ b erdazimer s odium i n m olluscum p atients with le sions]1, −2, −4) enrolled patients 6 months and older with 3–70 mollusca. Berdazimer or vehicle was applied once daily to all MC lesions for 12 weeks. Data from three Phase 3 studies were integrated for subgroup efficacy and safety assessments using several weighted meta‐analysis approaches. Patients with concurrent AD or a history of AD/eczema were categorized as AD+ subgroup (AD− when absent). Primary efficacy endpoint: complete lesion clearance at Week 12. Safety endpoints included adverse events (AEs) through Week 24 and local skin reactions through Week 12.
Results
Of 1598 enrolled patients, 209 (13.1%) were AD+. Baseline mean lesion counts were greater in AD+ (26.4) than AD− (19.3). Complete clearance rates were higher at Week 12 for berdazimer compared with vehicle in AD+ ( n = 209; 35.0% vs. 27.4%; odds ratio [OR], 1.3; 95% CI, 0.7–2.5) and AD− ( n = 1389; 29.1% vs. 18.9%; OR 1.8; 95% CI 1.4–2.4) subgroups. AEs in AD+ were application‐site pain (21.6% with berdazimer vs. 11.9% with vehicle), dermatitis (12.8% vs. 2.4%), and erythema (9.6% vs. 7.1%).
Conclusions
Berdazimer gel showed favorable efficacy regardless of AD status. Berdazimer‐induced erythema may be indistinguishable from AD symptoms or with inflammatory response upon resolution of molluscum.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Northwestern University Feinberg School of Medicine and the Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA.
- Department of Dermatology, George Washington University School of Medicine, Washington, DC, USA.
- Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Pediatric Department, Coastal Pediatric Research, Charleston, South Carolina, USA.
- Novan, Inc., Durham, North Carolina, USA.
- Synteract, Hampshire, UK.
ORCID-Profile: Amy S Paller, Lawrence J Green, Nanette Silverberg, Stephen Stripling, Martina Cartwright, Carolyn Enloe, Elaine Kearney Kowalewski, Tomoko Maeda-Chubachi
Förderung
- Novan Inc
Zitieren
APA
Paller, A. S., Green, L. J., Silverberg, N., Stripling, S., Cartwright, M., Enloe, C., Wells, N., Kowalewski, E. K., & Maeda-Chubachi, T. (2024). Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis. Pediatric Dermatology, 41(3), 438-444. https://doi.org/10.1111/pde.15575
Vancouver
Paller AS, Green LJ, Silverberg N, Stripling S, Cartwright M, Enloe C, et al. Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis. Pediatric Dermatology. 2024;41(3):438-444. doi:10.1111/pde.15575
BibTeX
@article{Paller2024,
author = {Paller, Amy S and Green, Lawrence J and Silverberg, Nanette and Stripling, Stephen and Cartwright, Martina and Enloe, Carolyn and Wells, Nick and Kowalewski, Elaine Kearney and Maeda-Chubachi, Tomoko},
title = {Berdazimer gel for molluscum contagiosum in patients with atopic dermatitis},
journal = {Pediatric Dermatology},
year = {2024},
volume = {41},
number = {3},
pages = {438--444},
doi = {10.1111/pde.15575}
}
EUVIMED